Use of a Disease Risk Score to Compare Serious Infections Associated With Anti-Tumor Necrosis Factor Therapy Among High- Versus Lower-Risk Rheumatoid Arthritis Patients

Arthritis Care and Research - United States
doi 10.1002/acr.21805
Full Text
Abstract

Available in full text

Categories
Rheumatology
Date
Authors
Publisher

Wiley

Related search

Risk of Serious Infection in Patients With Rheumatoid Arthritis

Japanese Journal of Clinical Immunology
2015English

The Risk of Hypersensitivity Associated With Biologic Use Among Medicare Patients With Rheumatoid Arthritis

Arthritis Care and Research
Rheumatology
2017English

Serious Infections in Rheumatoid Arthritis Offspring Exposed to Tumour Necrosis Factor Α Inhibitors: Cohort Study

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

Erratum To: Anti-Tumor Necrosis Factor-Α Therapy and Changes of Flow-Mediated Vasodilatation in Psoriatic and Rheumatoid Arthritis Patients

Internal and Emergency Medicine
Internal MedicineEmergency Medicine
2010English

Aspirin Use in Rheumatoid Arthritis Patients With Increased Risk of Cardiovascular Disease

ISRN Rheumatology
2013English

PMS73 Visualizing Treatment Patterns of Veteran Patients With Rheumatoid Arthritis Who Initiated Tumor Necrosis Factor Therapy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Risk of Diabetes Among Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2010English

Increased Risk of Thyroid Dysfunction Among Patients With Rheumatoid Arthritis

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Malignancy Risk in Australian Rheumatoid Arthritis Patients Treated With Anti-Tumour Necrosis Factor Therapy: Analysis of the Australian Rheumatology Association Database (ARAD) Prospective Cohort Study

BMC Musculoskeletal Disorders
RheumatologyOrthopedicsSports Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy